Press release
Leading Companies Solidify Their Presence in the Coronary Stents Market
Coronary Stents Market
Projected Growth Trajectory of the Coronary Stents Market
The coronary stents market is forecasted to reach a valuation of $17.76 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.3%. This growth is propelled by an aging global population with elevated cardiovascular risks and a rising preference for minimally invasive procedures. Additionally, the adoption of cutting-edge stent technologies and a greater emphasis on improving long-term vessel healing and patient results are critical factors supporting market expansion. Increased access to cardiac care in emerging regions further fuels this upward trend. Key market trends expected during the forecast period include greater use of drug-eluting and dual therapy stents, a shift toward minimally invasive coronary interventions, heightened efforts to lower restenosis and thrombosis risks, proliferation of bioresorbable and biodegradable stents, and demand for advanced materials and innovative designs.
Download a free sample of the coronary stents market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR
Prominent Companies Leading the Coronary Stents Industry
Several major corporations dominate the coronary stents market, including Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, and Minvasys.
In a notable development from November 2023, OrbusNeich Medical Group Holdings Limited, a medical device firm based in China, acquired Eucatech AG, a German coronary stent manufacturer. This strategic move aims to broaden OrbusNeich's cardiovascular product range, reinforce its position in the global angioplasty and stent markets, spur innovation in vascular intervention technologies, and enhance its commercial footprint across Europe and other vital regions.
View the full coronary stents market report:
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR
Innovative Trends Shaping the Coronary Stents Market
Leading industry players are focusing on developing next-generation products such as drug-eluting stents, which significantly reduce the likelihood of repeat procedures compared to traditional bare-metal stents. These stents are coated with medication that gradually releases drugs to prevent artery re-narrowing.
For instance, in May 2024, Abbott unveiled the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an improved design, a novel delivery mechanism, and unique sizing options tailored for complex cases. It maintains the hallmark drug coating that helps prevent artery blockages, sustaining the safety and effectiveness proven through over 120 clinical trials involving more than 120,000 patients.
Detailed Breakdown of Key Coronary Stents Market Segments
The coronary stents market can be categorized into several essential segments:
1) Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Other Technologies
3) Raw Material: Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer
4) Deployment Method: Self-Expandable Stents, Balloon-Expandable Stents
5) End Use: Hospitals and Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subcategories include:
- Dual Therapy Stents: Sirolimus-Eluting, Paclitaxel-Eluting, Everolimus-Eluting
- Radioactive Stents: Beta Radiation, Gamma Radiation, Other Radiation Types
- Thrombectomy Stents: Manual, Mechanical, Hydrodynamic
- Covered Stents: PTFE, ePTFE, Polyurethane, Other Covered Variants
- Bioresorbable Stents: Polymer-Based, Metal-Based, Ceramic-Based
- Biodegradable Stents: Polymeric, Magnesium-Based, Other Types
- Hybrid Stents: Hybrid Drug-Eluting, Hybrid Biodegradable or Metal, Other Hybrids
- Drug-Eluting Stents: Sirolimus-Eluting, Paclitaxel-Eluting, Everolimus-Eluting, Zotarolimus-Eluting, Other Variants
- Bare Metal Stents: Stainless Steel, Cobalt Chromium, Other Types
These classifications provide a comprehensive view of the evolving technologies and materials that are shaping the future of coronary stent therapies.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Companies Solidify Their Presence in the Coronary Stents Market here
News-ID: 4450432 • Views: …
More Releases from The Business Research Company
Trends in Growth, Market Segmentation, and Competitive Approaches Influencing th …
The infectious disease molecular diagnostics market is positioned for consistent expansion as advancements in technology and growing healthcare needs drive demand. With rising interest in rapid and precise diagnostic methods, especially in emerging markets, this sector is set to witness major growth over the next several years. The following analysis explores the current market size, key players, influential trends, and primary segments shaping the future of infectious disease molecular diagnostics.
Projected…
Drug-Coated Balloons Market: Segmentation, Major Trends, and Competitive Overvie …
The drug-coated balloons market is set for significant expansion in the coming years, driven by advancements in technology and growing demand in cardiovascular treatments. As new therapies and innovations emerge, this sector is attracting increasing attention from healthcare providers and investors alike. Let's explore the market's size, key drivers, leading companies, notable trends, and segmentation details to understand how this dynamic field is evolving globally.
Projected Growth and Market Size of…
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Knee …
The knee-assist exosuit market is set to experience remarkable expansion over the coming years, driven by technological advancements and growing demand across various sectors. This evolving field presents exciting opportunities in enhancing mobility, rehabilitation, and industrial applications. Here's a detailed overview of the market's potential, key players, trends, and segment breakdowns.
Projected Growth and Market Size Forecast for Knee-Assist Exosuits
The knee-assist exosuit market is anticipated to expand dramatically, reaching a valuation…
Leading Companies Advancing Innovation and Growth in the Interventional Neurolog …
The interventional neurology devices and equipment market is set to experience significant expansion in the coming years, driven by advancements in stroke treatment and neurovascular care. With emerging technologies and growing investment, this sector is poised for transformative growth and innovation. Let's dive into the market's size projections, key drivers, major players, emerging trends, and segmentation details to better understand its future trajectory.
Forecasted Market Size and Growth for Interventional Neurology…
More Releases for Stent
Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032.
What is the Airway Stent/Lung Stent Market and Why is It Significant?
The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,…
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
